Tacrolimus Pill
Phase 3Small molecule
Tacrolimus Pill is one of 48 small molecule programs targeting Liver Transplant. It is currently in Phase 3.
2
Indications
2
Total Trials
2
Active Trials
47
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
96 competitors in Liver Transplant
#DrugCompanyPhaseTrials
1Darbepoetin
BayerPhase 3
Prothrombin Complex Concentrate
CSL BehringPhase 3
Rezzayo
MMundipharma (China) Pharmaceutical Co. Ltd
Phase 3
Tacrolimus Pill
EEdward Geissler
Phase 3
Lenvima
EisaiPreclinical
Octreotide
Johnson & JohnsonPreclinical
Beyfortus
BeiGenePreclinical
Prostigmin
Merck & Co.Preclinical
Myfortic
NovartisPreclinical
Cyklokapron
JJ Molner
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Tacrolimus Pill. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- EEdward Geissler